Abpro Holdings, Inc. (ABPO) Stock Price & Analysis
Abpro Holdings, Inc. (ABPO) fell 0.49% to USD 0.2 as of July 25, 2026 at 08:08 UTC, according to Nexqual real-time market data.
ABPO last closed at USD 0.21; the session ranged USD 0.19–0.19 on volume of 249 shares. Market capitalization is $1.20M, with a 52-week range of USD 0.09–13.65 (PNK). Source: Nexqual, July 25, 2026 at 08:08 UTC.
Key Statistics (as of July 25, 2026 at 08:08 UTC)
| Price | USD 0.2 |
|---|---|
| Change | ▼ 0.49% (down) |
| Previous Close | USD 0.21 |
| Open | USD 0.19 |
| Day Range | USD 0.19 – 0.19 |
| 52-Week Range | USD 0.09 – 13.65 |
| Volume | 249 shares |
| Market Cap | $1.20M |
| Exchange | PNK |
Technical Analysis (ABPO)
Nexqual's technical model rates ABPO "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 08:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 50.29 (neutral) |
| vs SMA50 | Below (USD 0.21) |
| MACD | -0 (negative) |
Analyst Ratings (ABPO)
Wall Street analysts rate ABPO "None", per Nexqual as of July 25, 2026 at 08:08 UTC.
| Consensus Rating | None |
|---|
Earnings (ABPO)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD -0.63 vs est -1.2 ▲ beat |
| 2025-06-30 | USD -1.5 vs est -1.2 ▼ miss |
| 2025-03-31 | USD -2.4 vs est -1.2 ▼ miss |
| 2024-12-31 | USD -9.6 vs est -1.2 ▼ miss |
Source: Nexqual, July 25, 2026 at 08:08 UTC.
Financials & Fundamentals (ABPO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.74 |
| Total Cash | $5.40M |
| Total Debt | $294,000 |
| Free Cash Flow | $-11.50M |
Source: Nexqual, July 25, 2026 at 08:08 UTC.
Financial Health Score (ABPO)
Nexqual rates Abpro Holdings, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 08:08 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $5M cash, no debt |
| Cash Flow | Weak — FCF negative: -$12M, burning cash |
| Efficiency | Mixed — No data |
Ownership (ABPO)
| Insider Ownership | +16.09% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 5.90M |
| Float | 4.95M |
| Short % of Float | +2.56% |
Source: Nexqual, July 25, 2026 at 08:08 UTC.
Leadership (ABPO)
Abpro Holdings, Inc. is led by Jin Wook Suk (age 56), CEO & Chairman of the Board, per Nexqual as of July 25, 2026 at 08:08 UTC.
| CEO & Chairman of the Board | Jin Wook Suk (age 56) |
|---|
Major Backers & Investors (ABPO)
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.18% |
Source: Nexqual, July 25, 2026 at 08:08 UTC.
From Abpro Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-04-15)
Key Strengths & Strategy (as disclosed to the SEC)
- Abpro Holdings, Inc., a biotechnology company, focuses on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease in the United States.
- Its platforms include DiversImmune, an antibody discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides flexibility to combine antibody building blocks in different combinations and orientations to create fit-for-purpose novel full-length multispecific antibody constructs.
- The company's lead product candidates include ABP-102, a next-generation immuno-oncology TetraBi antibody targeting HER2 and CD3 developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibits VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration.
- It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDCO | Blue Dolphin Energy Co. | USD 4.3 | ▲ 0.7% |
| ROYL | Royale Energy, Inc. | USD 0.01 | ▲ 0% |
| BRN | Barnwell Industries, Inc. | USD 1.07 | ▲ 3.88% |
| PDC | Perpetuals.com Ltd | USD 3.6 | ▼ 6.98% |
| ISRL | Israel Acquisitions Corp | USD 12.4 | ▲ 4.11% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:08 UTC. This page is informational and not investment advice.